{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:45:35Z","timestamp":1768207535135,"version":"3.49.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To explore the effects of balloon pulmonary angioplasty (BPA) on cardiac and pulmonary functions and complications in patients with chronic thromboembolic pulmonary hypertension (CTEPH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      From February 2023 to December 2024, 100 patients with CTEPH at our hospital underwent BPA treatment were selected. The WHO cardiac function classification, right heart catheterization parameters, cardiac function indexes, levels of NT-proBNP, TNF-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      and IL-6, exercise tolerance, pulmonary function indexes, pulmonary artery pressure, and blood gas indexes were compared before BPA and 3\u2009months after the last BPA. The BPA-related complications were recorded.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared with before BPA, the WHO cardiac function classification of Grade I, Grade II and Grade III was significantly improved 3\u2009months after the last BPA (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.020,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.000), the mPAP and PVR were significantly lower (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), the CI was significantly higher (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), the TAPSE, RVFAC and EDV were significantly higher (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), the TVR was significantly lower (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), the 6-MWD was significantly longer (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), the FVC, FEV1 and FEV1\/FVC were significantly higher (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), the levels of pulmonary artery systolic pressure and pulmonary artery diastolic pressure were significantly lower (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), the levels of NT-proBNP, TNF-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      and IL-6 were significantly lower, the PaO\n                      <jats:sub>2<\/jats:sub>\n                      level was significantly higher (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), as well as the PaCO\n                      <jats:sub>2<\/jats:sub>\n                      level was significantly lower (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). However, there were no significant differences in ESV and LVEF between before BPA and 3\u2009months after the last BPA (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;gt;\u20090.05). In addition, there were 5 cases of hemoptysis, 1 case of reperfusion pulmonary edema, and no other complications occurred.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>BPA can improve the exercise tolerance, cardiac and pulmonary functions, and blood gas level of patients with CTEPH, and the incidence of complications is relatively low. However, due to the limitations of the single-arm design, the results of this study need to be further verified through randomized controlled trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1689193","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:45:44Z","timestamp":1768196744000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of balloon pulmonary angioplasty on cardiac and pulmonary functions and complications in patients with chronic thromboembolic pulmonary hypertension"],"prefix":"10.3389","volume":"12","author":[{"given":"Heng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingzhe","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ccm.2020.11.014","article-title":"Chronic thromboembolic disease and chronic thromboembolic pulmonary hypertension","volume":"42","author":"Lang","year":"2021","journal-title":"Clin Chest Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00408-022-00539-w","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"200","author":"Teerapuncharoen","year":"2022","journal-title":"Lung"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"160119","DOI":"10.1183\/16000617.0119-2016","article-title":"Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension","volume":"26","author":"Lang","year":"2017","journal-title":"Eur Respir Rev"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11886-021-01573-5","article-title":"Chronic thromboembolic pulmonary hypertension: the bedside","volume":"23","author":"Matusov","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1136\/heartjnl-2019-316291","article-title":"Chronic thromboembolic pulmonary hypertension: interventional approaches","volume":"106","author":"Hoole","year":"2020","journal-title":"Heart"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/S2213-2600(23)00292-8","article-title":"Chronic thromboembolic pulmonary hypertension: realising the potential of multimodal management","volume":"11","author":"Delcroix","year":"2023","journal-title":"Lancet Respir Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"160111","DOI":"10.1183\/16000617.0111-2016","article-title":"Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension","volume":"26","author":"Jenkins","year":"2017","journal-title":"Eur Respir Rev"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.110.015008","article-title":"Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry","volume":"124","author":"Pepke-Zaba","year":"2011","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jtcvs.2009.12.056","article-title":"Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension","volume":"141","author":"Freed","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2213-2600(24)00027-4","article-title":"Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study","volume":"12","author":"Ghofrani","year":"2024","journal-title":"Lancet Respir Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12928-021-00775-6","article-title":"Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension","volume":"37","author":"Hirakawa","year":"2022","journal-title":"Cardiovasc Interv Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1016\/j.jacc.2013.10.024","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"62","author":"Kim","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s12928-019-00637-2","article-title":"Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension","volume":"35","author":"Ikeda","year":"2020","journal-title":"Cardiovasc Interv Ther"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejrad.2016.12.013","article-title":"Efficacy and safety of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension guided by cone-beam computed tomography and electrocardiogram-gated area detector computed tomography","volume":"89","author":"Ogo","year":"2017","journal-title":"Eur J Radiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1602409","DOI":"10.1183\/13993003.02409-2016","article-title":"Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience","volume":"49","author":"Olsson","year":"2017","journal-title":"Eur Respir J"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2401324","DOI":"10.1183\/13993003.01324-2024","article-title":"Definition, classification and diagnosis of pulmonary hypertension","volume":"64","author":"Kovacs","year":"2024","journal-title":"Eur Respir J"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijcard.2015.08.155","article-title":"Six-minute walking distance and decrease in oxygen saturation during the six-minute walk test in pediatric pulmonary arterial hypertension","volume":"202","author":"Douwes","year":"2016","journal-title":"Int J Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.chest.2023.03.029","article-title":"Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension","volume":"164","author":"Yang","year":"2023","journal-title":"Chest"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/S2213-2600(22)00214-4","article-title":"Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study","volume":"10","author":"Ja\u00efs","year":"2022","journal-title":"Lancet Respir Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S2213-2600(22)00171-0","article-title":"Balloon pulmonary angioplasty versus riociguat in inoperable chronic thromboembolic pulmonary hypertension (MR BPA): an open-label, randomised controlled trial","volume":"10","author":"Kawakami","year":"2022","journal-title":"Lancet Respir Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1253\/circj.CJ-19-0161","article-title":"Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension - a systematic review and Meta-analysis","volume":"83","author":"Zoppellaro","year":"2019","journal-title":"Circ J"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s10741-020-10070-w","article-title":"Balloon pulmonary angioplasty vs. pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis","volume":"26","author":"Zhang","year":"2021","journal-title":"Heart Fail Rev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113608","article-title":"Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: impact on clinical and hemodynamic parameters, quality of life and risk profile","volume":"9","author":"Jansa","year":"2020","journal-title":"J Clin Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.hrtlng.2021.11.003","article-title":"Increased pulmonary arterial compliance after balloon pulmonary angioplasty predicts exercise tolerance improvement in inoperable CTEPH patients with lower pulmonary arterial pressure","volume":"52","author":"Umemoto","year":"2022","journal-title":"Heart Lung"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12931-019-1211-y","article-title":"Improved hemodynamics and cardiopulmonary function in patients with inoperable chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty","volume":"20","author":"Jin","year":"2019","journal-title":"Respir Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00270-022-03323-8","article-title":"Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis","volume":"46","author":"Kennedy","year":"2023","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1802095","DOI":"10.1183\/13993003.02095-2018","article-title":"French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension","volume":"53","author":"Brenot","year":"2019","journal-title":"Eur Respir J"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.124.068610","article-title":"Worldwide CTEPH registry: long-term outcomes with pulmonary endarterectomy, balloon pulmonary angioplasty, and medical therapy","volume":"150","author":"Delcroix","year":"2024","journal-title":"Circulation"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"8217","DOI":"10.2147\/JIR.S517285","article-title":"Association of Systemic Inflammatory Response Index with disease severity and adverse outcome in chronic thromboembolic pulmonary hypertension","volume":"18","author":"Li","year":"2025","journal-title":"J Inflamm Res"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1111\/ejn.15992","article-title":"Pro-inflammatory cytokines IL-1\u03b1, IL-6 and TNF-\u03b1 in major depressive disorder: sex-specific associations with psychological symptoms","volume":"57","author":"Elgellaie","year":"2023","journal-title":"Eur J Neurosci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.jacc.2021.07.045","article-title":"NT-proBNP response to heart failure therapies: an imperfect surrogate","volume":"78","author":"Cunningham","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11082211","article-title":"Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension in Greece: data from the Hellenic pulmonary hypertension registry","volume":"11","author":"Karyofyllis","year":"2022","journal-title":"J Clin Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/cells11091491","article-title":"Changes in inflammatory markers in patients with chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty","volume":"11","author":"Mago\u0144","year":"2022","journal-title":"Cells"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"103857","DOI":"10.1016\/j.resp.2022.103857","article-title":"Neural respiratory drive in chronic thromboembolic pulmonary hypertension: effect of balloon pulmonary angioplasty","volume":"299","author":"Blanquez-Nadal","year":"2022","journal-title":"Respir Physiol Neurobiol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/j.iccl.2024.04.003","article-title":"Pathogenesis, diagnosis, and Management of Chronic Thromboembolic Pulmonary Hypertension","volume":"12","author":"Elhage Hassan","year":"2023","journal-title":"Interv Cardiol Clin"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3760\/cma.j.issn.0376-2491.2020.06.008","article-title":"Efficacy and safety of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension","volume":"100","author":"Tao","year":"2020","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.117.004029","article-title":"Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: results of a multicenter registry","volume":"10","author":"Ogawa","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1689193\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:45:47Z","timestamp":1768196747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1689193\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":38,"alternative-id":["10.3389\/fmed.2025.1689193"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1689193","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1689193"}}